LITTLE ELM, Texas--(BUSINESS WIRE)--Retractable Technologies, Inc. (AMEX: RVP), a leading maker of safety needle devices, announced today that Queensland Health, a department within the Queensland government, has awarded Retractable a one-year contract to supply its VanishPoint® automated retraction syringes to all of Queensland Health’s 202 acute care facilities. The contract, which is effective immediately and renewable for two years, follows a successful two-year clinical study at Princess Alexandra Hospital in Brisbane, Australia, Queensland’s capital. Virtually all of the healthcare facilities in Queensland and in Australia’s five other states are government-operated.
